Skip to content

A clinical study comparing the effects of oxytocin administered at different rates during planned caesarean surgery.

Comparative study of different infusion rates of oxytocin in elective caesarean section.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/046096
Enrollment
90
Registered
2022-09-30
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery

Interventions

Intervention1: Oxytocin infusion 5 IU/hour: All patients will receive 1 IU of oxytocin intravenously over the duration of one minute when the umbilical cord is clamped. Following this injection, an ox

Sponsors

All India Institute of Medical Sciences Patna
Lead Sponsor
Amarjeet Kumar
Collaborator
Rajnish Kumar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant patients undergoing elective caesarean section in spinal anaesthesia will be included in the study. 1. Uncomplicated, singleton pregnancy 2. ASA class 1 & 2

Exclusion criteria

Exclusion criteria: 1. Patients with multiple pregnancies 2. Complicated pregnancies, risk factors for postpartum haemorrhage (PPH) 3. Contraindication to spinal anaesthesia and 4. Patients in active labour.

Design outcomes

Primary

MeasureTime frame
To measure the total estimated blood loss (EBL) in intraoperative period after the infusion of 5U/h and 2.5 U/h of oxytocin during elective caesarean section under spinal anaesthesia.Timepoint: Intraoperative period

Secondary

MeasureTime frame
To measures the following after the administration of oxytocin: 1. Adequacy of uterine tone. 2. Need for additional uterotonics. 3. Incidence of postpartum haemorrhage (PPH). 4. Any oxytocin-related side effects for example: tachycardia, hypotension, chest pain.Timepoint: Intraoperative period

Countries

India

Contacts

Public ContactKunal Singh

All India Institute of Medical Sciences Patna

drsinghkunal@gmail.com9411514945

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026